{"transactions":[{"id":1785533,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-09-07T16:32:10.000Z","date":"2023-09-05","kind":"grant","planned":false,"acquired":true,"shares":112147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"37,382 options vest on June 26, 2024, 37,382 options vest on June 26, 2025 and 37,383 vest on June 26, 2026."}],"balance_after":123775,"derivative":{"exercise_price":0.76,"expiration_date":"2033-09-05","underlying":"Common Stock","underlying_shares":112147},"source":{"system":"sec-edgar","filing":"0001213900-23-075010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679825/000121390023075010/ownership.xml","form_type":"4"}},{"id":2519098,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Equity Appreciation Rights Unit","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":250,"price":3.5,"value":875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2024-12-16","underlying":"Common Stock, par value $0.001","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2519097,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":175000,"price":5.54,"value":969500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":3.96,"expiration_date":"2031-01-08","underlying":"Common Stock, par value $0.001","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2519096,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":5.16,"value":516000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":4.34,"expiration_date":"2030-01-27","underlying":"Common Stock, par value $0.001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2519095,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":7.03,"value":351500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":2.47,"expiration_date":"2028-12-14","underlying":"Common Stock, par value $0.001","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2519094,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":150000,"price":5.86,"value":879000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":3.64,"expiration_date":"2027-12-08","underlying":"Common Stock, par value $0.001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2519093,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:04.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":4.84,"value":484000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option and EAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger, all unvested stock options (\"Options\") and equity appreciation rights (\"EARs\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option and EAR award."}],"balance_after":0,"derivative":{"exercise_price":4.66,"expiration_date":"2026-12-15","underlying":"Common Stock, par value $0.001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-136410","document":"tm2131118-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136410/tm2131118-9_4seq1.xml","form_type":"4"}},{"id":2909171,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-12T16:23:25.000Z","date":"2021-01-08","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from January 8, 2021, the date of grant."}],"balance_after":175000,"derivative":{"exercise_price":3.96,"expiration_date":"2031-01-08","underlying":"Common stock, par value $0.001","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001593968-21-000118","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396821000118/primary_01.xml","form_type":"4"}},{"id":3298555,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-29T16:18:29.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from January 27, 2020, the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":4.34,"expiration_date":"2030-01-27","underlying":"Common stock, par value $0.001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001593968-20-000225","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396820000225/primary_01.xml","form_type":"4"}},{"id":3726278,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President, CMO"}}],"security":"Option (right to buy)","published_at":"2018-12-18T10:10:09.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":50000,"price":2.47,"value":123500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Only represents derivative securities of this class."}],"balance_after":50000,"derivative":{"exercise_price":2.47,"exercise_date":"2019-12-14","expiration_date":"2028-12-14","underlying":"Common Stock, par value $0.001","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001593968-18-001603","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396818001603/primary_01.xml","form_type":"4"}},{"id":4134446,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-12T16:10:23.000Z","date":"2017-12-08","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments over 3 years from December 8, 2017, the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":150000,"derivative":{"exercise_price":3.64,"expiration_date":"2027-12-08","underlying":"Common Stock, par value $0.001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001593968-17-001353","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396817001353/primary_01.xml","form_type":"4"}},{"id":4518406,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":109887,"kind":"person","name":"Ryan John L","position":1,"cik":"0001679825","reported_name":"Ryan John L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-16T20:23:27.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":100000,"price":4.66,"value":466000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in two equal annual installments over 2 years from December 15, 2016, the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":100000,"derivative":{"exercise_price":4.66,"expiration_date":"2026-12-15","underlying":"Common Stock, par value $0.001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001593968-16-001350","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396816001350/primary_01.xml","form_type":"4"}}]}